HOME >> BIOLOGY >> NEWS
Underserved US minorities face 'unequal burden of cancer' that must be corrected

Barriers to healthy lifestyles, early detection services and good medical care are contributing to higher cancer incidence and mortality rates for African Americans and other medically underserved minorities in this country, when compared with white U.S. citizens.

As a result, the War on Cancer declared about three decades ago by President Nixon -- cannot be won until this "unequal burden of cancer" is corrected, according to reports by a panel of cancer clinicians and public health officials in the March issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research (AACR).

"In our efforts to reduce disparities, we must identify and remove all of the barriers that prevent the benefits of research from reaching all of the people," wrote Harold P. Freeman, M.D., director of the Ralph Lauren Center for Cancer Care and Prevention in New York City and director of the Center to Reduce Cancer Health Disparities at the National Cancer Institute.

"These barriers are a major cause of health disparities," he added. "This is a national issue, a policy issue." Added Frederick P. Li, M.D., of the Dana-Farber Cancer Institute in Boston who assembled the panel for an October 2001: "The burden of cancer is not equally distributed within the U.S. population, but differs by race, ethnicity and, other demographic characteristics."

"Clearly, it is essential that we address this disparity and work to ensure that all Americans have equal access and quality cancer care."

Statistics tell part of the story, particularly for African Americans:

African Americans are 30 percent more likely to die from cancer than white Americans. In 2003, an estimated 132,700 new cancers will be diagnosed among African Americans and 63,100 deaths will be recorded. In 1992-1999, overall age-adjusted U.S. incidence rates for all cancers combined (per 1 million population) were 527 for African Americans and 480 fo
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
25-Mar-2003


Page: 1 2 3 4

Related biology news :

1. White House lauds Physiological Society for mentoring underrepresented minorities in biomedicine
2. Study: overweight more common among early-maturing girls, especially minorities
3. Improved nutrition could reduce malaria burden worldwide
4. Obesity in Costa Rican children alarming, likely future health burden
5. Studies offer data on potential impact of Reminyl on caregiver burden in Alzheimers disease
6. Scientists find drastic underestimations of malaria morbidity, mortality, and economic burden
7. Environmental health burdens of poor Asian, Native American, African American and Hispanic communities featured at special session of Soc. of Tox.
8. Distinctive genetic program guides breast cancers deadly spread
9. Scientists find protein that controls prostate cancers spread
10. U-M scientists find cancers genetic core: 67 genes universally activated in human cancer
11. U-M scientists reveal prostate cancers molecular fingerprint. Study links proteins to patient prognosis.

Post Your Comments:
(Date:5/22/2013)... endanger the whole organism, as they may lead to ... Munich now report how byproducts of respiration cause mispairing ... in our cells controls the form and function of ... this are encoded in the linear sequence of the ... cytosine (C), guanine (G) and thymine (T). Random changes ...
(Date:5/22/2013)... and wild plants have slowed in recent years, according ... University of Leeds and the Naturalis Biodiversity Centre in ... the diversity of species in Britain, Belgium and the ... picture brightened markedly after 1990, with a slowdown in ... wild plants. , Professor Bill Kunin, Professor ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Encouraging signs for bee biodiversity 2Encouraging signs for bee biodiversity 3
(Date:5/22/2013)... New York (PRWEB) May 22, 2013 ... the 3rd Annual Disruptive Innovations to Advance Clinical Trials ... Copley Plaza Hotel in Boston, MA. , Disruptive ... Janssen Pharmaceuticals and more share bold approaches to reduce ... , “Disruptive innovation needs to be big, or ...
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... IL (PRWEB) May 22, 2013 Alton Housing ... dated May 15, 2013 said that their presence has ... other bed bug sufferers avoid such big spending, My Cleaning ... inexpensively. , It was said in the report that ... exterminator, MCP related. Apart from that, its employees also attended ...
(Date:5/21/2013)... , May 22, 2013 ... drug-only formulation of glycopyrronium bromide designed using Prosonix, particle ... company developing a portfolio of inhaled Respiratory Medicines ... study with PSX1002 that will assess its effect on ... doses in patients with moderate to severe chronic obstructive ...
Breaking Biology Technology:Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4Bed Bugs Cost Alton Housing Authority $35,000; New Help, How to Kill Bed Bugs With Less Expense, Introduced by My Cleaning Products 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4
Cached News: